Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$265K Buy
+1,172
New +$249K 0.04% 274
2024
Q4
– Sell
-500
Closed -$96.9K – 179
2024
Q3
$96.9K Hold
500
– – 0.04% 305
2024
Q2
$116K Hold
500
– – 0.06% 225
2024
Q1
$108K Hold
500
– – 0.05% 258
2023
Q4
$129K Hold
500
– – 0.07% 193
2023
Q3
$129K Hold
500
– – 0.07% 169
2023
Q2
$142K Hold
500
– – 0.08% 157
2023
Q1
$139K Hold
500
– – 0.08% 155
2022
Q4
$138K Hold
500
– – 0.08% 149
2022
Q3
$134K Buy
+500
New +$106K 0.08% 144

Other funds holding BIIB

Alta Advisers's BIIB Position: Q3 2026 in Review

Alta Advisers opened a new position in Biogen (BIIB) in Q3 2026: 1,172 shares worth $265K. The stake represents 0.04% of the portfolio and ranks #274 among its holdings. This is a return to the name: Alta Advisers previously reported a position in BIIB as recently as Q3 2024.

Alta Advisers first reported a position in BIIB in Q3 2022 and has held it in 10 quarters since. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Alta Advisers held 1,172 shares of Biogen worth $265K as of Q3 2026.
  • Biogen was a new Alta Advisers position in Q3 2026.
  • Biogen made up 0.04% of Alta Advisers's portfolio in Q3 2026, its #274 holding.
  • Alta Advisers first reported a position in Biogen in Q3 2022 and has held it in 10 quarters since.
  • 1,062 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Alta Advisers's 13F filing for Q3 2026, filed 2 Nov 2026.